The Business Times

Biolidics chairman to step down at later date amid search for replacement

Sharanya Pillai

Sharanya Pillai

Published Fri, Sep 29, 2023 · 06:49 PM
    • The additional time will allow for a smooth handover of duties, says Biolidics, which previously developed Covid-19 PCR tests (pictured).
    • The additional time will allow for a smooth handover of duties, says Biolidics, which previously developed Covid-19 PCR tests (pictured). PHOTO: BIOLIDICS

    GAVIN Mark McIntyre, the independent chairman of Catalist-listed Biolidics , will leave his post on Nov 30 – instead of Friday (Sep 29), as previously announced when he resigned.

    This will give Biolidics’ board and nominating committee more time to identify and appoint one or more suitable replacements, the company said in a bourse filing on Friday. Besides chairing the board, McIntyre also chairs its audit committee.

    The additional time will allow for a smooth handover of duties, and comes at the request of the other members of the board, Biolidics added.

    Separately, the company is also seeking a new sponsor, as announced on Thursday. United Overseas Bank has terminated its continuing sponsorship agreement with the company, citing “commercial reasons”.

    Biolidics shares ended Friday at S$0.014, up 7.7 per cent or S$0.001.

    Biolidics

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More